Nike slumps as the sneaker and apparel company sees sales softening in the second half of fiscal 2024, while Karuna Therapeutics soars on a deal to be acquired by Bristol Myers for about $14 billion.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles